Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II-Reference-Cited by-同舟云学术

Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II

Published:2019-07 Issue:7 Volume:29 Page:517-524
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Frongia A.L.,Natera-de Benito D.,Ortez C.,Alarcón M.,Borrás A.,Medina J.,Vigo M.,Padrós N.,Moya O.,Armas J.,Carrera-García L.,Expósito-Escudero J.,Cuadras D.,Bernal S.,Martorell L.,Colomer J.,Nascimento A.

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference48 articles.

1. Spinal muscular atrophies;Darras,2015

2. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA);Wirth;Hum Mutat,2000

3. Spinal muscular atrophy: diagnosis and management in a new therapeutic era;Arnold;Muscle Nerve,2015

4. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens;Sugarman;Eur J Hum Genet.,2012

5. Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling;Cusin;J Med Genet,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy;Journal of Neurology;2024-09-06

2. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

3. Molecular mechanisms and therapeutic strategies for neuromuscular diseases;Cellular and Molecular Life Sciences;2024-04-28

4. Respiratory function in a large cohort of treatment-naïve adult spinal muscular atrophy patients: a cross-sectional study;Neuromuscular Disorders;2023-12

5. Efficacy and safety of salbutamol in treatment of children with later-onset spinal muscular atrophy;Journal of Zhejiang University (Medical Sciences);2023-12-01